SEARCH

SEARCH BY CITATION

References

  • 1
    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:32553264.
  • 2
    Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al; for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final results. JAMA. 1993;270:713724.
  • 3
    Grimm RH, Margolis KL, Papademetriou V, Cushman WC, Ford CE, Bettencourt J, et al; for the ALLHAT Collaborative Research Group. Baseline characteristics of the 42,448 high risk hypertensives enrolled in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertens. 2001;37:1927.
  • 4
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:29812997.
  • 5
    Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al; for the VALUE Trial Group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:20222031.
  • 6
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Diuretic Versus α-Blocker as First-Step Antihypertensive Therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertens. 2003;42:239246.
  • 7
    Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, et al; for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group. The role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Circulation. 2006;113:22012210.
  • 8
    Davis BR, Furberg CD, Wright JT, Cutler JA, Whelton P; for the ALLHAT Collaborative Research Group. ALLHAT: setting the record straight. Ann Intern Med. 2004;141:3946.
  • 9
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid Lowering-Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2000;283:19671975.
  • 10
    Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, et al; for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens. 1996;9:342360.
  • 11
    Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, et al; for the ALLHAT Collaborative Research Group. Verification of heart failure events in ALLHAT. Am Heart J. 2007:153;4253.
  • 12
    Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med. 1994;13:153162.
  • 13
    Davis BR, Ford CE, Boerwinkle E, Arnett D, Eckfeldt J, Black H. Imputing gene-treatment interactions when the genotype distribution is unknown using case-only and putative placebo analysis – a new method for the Genetics of Hypertension Associated Treatment (GenHAT) Study. Stat Med. 2004;23:24132427.
  • 14
    Little RJA, Rubin DB. Statistical Analysis with Missing Data. Second edition. New York, NY: Wiley-Interscience; 2002.
  • 15
    Wright JT, Dunn KJ, Cutler JA, Davis BR, Cushman WC, Ford CE, et al; for the ALLHAT Collaborative Research Group. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;295:15951608.
  • 16
    Stamler R, Stamler J, Grimm R, Gosch FC, Elmer P, Dyer A, et al Nutritional Therapy for High Blood Pressure. Final Report of a four-year Randomized Controlled Trial- The Hypertension Control Program. JAMA. 1987;257:14841491.
  • 17
    HDFP Cooperative Group. Five-year findings of the HDFP: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242:25622571.
  • 18
    Froom J, Trilling JS, Yeh S, Gomolin IH, Grimson RC. Withdrawal of antihypertensive medications. J Am Board Fam Pract. 1997;10:249258.
  • 19
    Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:16851697.